Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk

Volume: 35, Issue: 10, Pages: 1069 - 1079
Published: Sep 7, 2021
Abstract
Nearly 5% of individuals in the USA had serious thoughts of suicide in 2019 and over 30% of individuals suffering with major depressive disorder reported suicidal ideation with 2 million of those reporting suicidal ideation with some level of intent. However, options to treat depressed individuals considered at imminent risk of suicide remain limited. Until the recent approval of esketamine in the treatment of patients with major depressive...
Paper Details
Title
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk
Published Date
Sep 7, 2021
Journal
Volume
35
Issue
10
Pages
1069 - 1079
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.